Seeing Is Believing
Currently out of the existing stock ratings of Andrew Baum, 21 are a HOLD (33.87%), 39 are a BUY (62.9%), 2 are a SELL (3.23%).
Analyst Andrew Baum works at CITI with a stock forecast success ratio of 62.99% fulfilled within 365.91 days on average.
Andrew Baum’s has documented 128 price targets and ratings displayed on 11 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on MRK, Merck mpany at 03-Jan-2024.
Analyst best performing recommendations are on LLY (ELI LILLY AND COMPANY).
The best stock recommendation documented was for LLY (ELI LILLY AND COMPANY) at 7/26/2023. The price target of $525 was fulfilled within 16 days with a profit of $74.01 (16.41%) receiving and performance score of 10.26.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
195
$27.11 (16.15%)
185
28 days ago
10/12 (83.33%)
$14.65 (8.12%)
191
Buy
189
$21.11 (12.57%)
181
2 months 18 days ago
9/11 (81.82%)
$15.71 (9.07%)
252
Buy
195
$27.11 (16.15%)
180
2 months 18 days ago
9/10 (90%)
$21.71 (12.53%)
445
Hold
165
$-2.89 (-1.72%)
157
3 months 7 days ago
11/11 (100%)
$2.96 (1.83%)
314
Buy
180
$12.11 (7.21%)
195
3 months 21 days ago
3/5 (60%)
$21.06 (13.25%)
496
Which stock is Andrew Baum is most bullish on?
Which stock is Andrew Baum is most reserved on?
What Year was the first public recommendation made by Andrew Baum?